Search

everythinglearnresearchcommunity

for

Search:↓

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Formononetin may help protect the brain and treat neurological diseases.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

LncRNA MTC boosts growth of goat skin cells, improving cashmere quality.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Nanofat injections may improve hair graft survival in scarred areas.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Different diets change the fat composition in mouse skin, often reducing beneficial omega-3 fatty acids.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.